SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT
Exhibit 10.1
SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT
This Second Amendment to Executive Employment Agreement (the “Second Amendment”) is made and entered effective as of February 1, 2023 (the “Effective Date”) by and between Xxxxx Therapeutics, Inc., a Delaware corporation (“Company”), and Xxxxxxx Xxxxxxx (“Executive”) (each a “Party” and collectively, the “Parties”).
WHEREAS, Company currently employs Executive under the terms of an Executive Employment Agreement dated January 1, 2020, as amended by that certain Amendment to Executive Employment Agreement, effective as of November 10, 2022 (as amended, the “Employment Agreement”);
(a) Base Salary. Company shall pay Executive a base salary (the “Base Salary”) at the annual rate of Four Hundred Fifty-Nine Thousand Dollars ($459,000).
This Second Amendment may be executed in two or more counterparts, and by different parties hereto on separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. For all purposes, an electronic signature shall be treated as an original.
[signatures appear on following page]
COMPANY:
Xxxxx Therapeutics, Inc.
By: /s/ Xxxxx Xxxxxxxxx, M.D.
Name: Xxxxx Xxxxxxxxx, M.D.
Title: Chief Executive Officer
EXECUTIVE:
Xxxxxxx Xxxxxxx
/s/ Xxxxxxx Xxxxxxx
[Signature Page to Amendment to Executive Employment Agreement]